Abstract:
A CONTINUOUS PROCESS FOR THE PRODUCTION OF CAPROLACTAM, INCLUDING ACETYLATION OF CYCLOHEXANONE WITH ACETIC ANHYDRIDE AND KETENE (WHICH REACTS WITH ACETIC ACID FORMED IN THE ACETYLATION REACTION). THE CYCLOHEXENYL ACETATE FORMED IS THEN NITRATED WITH CONCENTRATED NITRIC ACID AND THE RESULTING NITROCYCLOHEXANONE SEPARATED BY DISTILLATION. ACETIC ANHYDRIDE IS RECYCLED TO THE ACETYLATION REACTION, AND ACETIC ACID TOGETHER WITH MAKEUP ACETIC ACID IS PYROLYZED TO KETENE, WHICH IS ALSO USED IN THE ACETYLATION REACTION. THE NITROCYCLOHEXANONE IS THEN CLEAVED WITH AMMONIUM HYDROXIDE TO FORM THE AMMONIUM SALT OF 6-NITRO CAPROIC ACID, WHICH IS THEN REDUCED WITH HYDROGEN AND A HYDROGENATION CATALYST TO PRODUCE 6-AMINO CAPROIC ACID. THIS INTERMEDIATE IS THEN SEPARATED BY REMOVING AMMONIA, WHICH IS RECYCLED WITH MAKEUP AMMONIA TO THE CLEAVAGE REACTION. THE AQUEOUS 6-AMINO CAPROIC ACID IS THEN HEATED IN DILUTE AQUEOUS SOLUTION, 5% TO 25% W./V., TO CYCLIZE TO CAPROLACTAM. THE CAPROLACTAM IS THEN EXTRACTED WITH AN ORGANIC SOLVENT, SUCH AS TRICHLOROETHYLENE, AND THE UNCONVERTED AQUEOUS AMINO CAPROIC ACID RECYCLE TO THE CYCLIZATION STEP. SOLVENT IS THEN REMOVED AND THE CAPROLACTAM PURIFIED BY KNOWN MEANS. AN IMPORTANT PART OF THE PROCESS IS THAT THERE IS NO AMMONIUM SULFATE FORMED, WHICH IN EARLIER PROCESSES WAS AN UNDESIRABLE BY-PRODUCT. THE AMMONIA USED IN THE CLEAVAGE REACTION IS RECYCLED AND THERE IS NO LARGE LOSS OF RAW MATERIAL.
Abstract:
A process for the synthesis of N-alkylated lactams via reductive alkylation. The process of the present disclosure may be conducted by the addition of an aldehyde to a lactam in the presence of a catalyst under a reducing atmosphere.
Abstract:
This invention relates to a process for co-producing cyclohexanol and alkanol, including a cyclohexene esterification step and a cyclohexyl ester hydrogenation step. This invention further relates to a process for further producing cyclohexanone or caprolactam, starting from the co-producing process, and an apparatus for co-producing cyclohexanol and alkanol. The process for co-producing cyclohexanol and alkanol of this invention is environment-friendly, with low production cost and highly improved atom economy.
Abstract:
Lactams, notably ε-caprolactam, are prepared from alkyl cyanovalerates, themselves obtained from unsaturated nitrile compounds, by contacting same, in gaseous state, with hydrogen in the presence of hydrogenation/cyclization catalysts, and then condensing the gas stream thus formed, without intermediate separation of any alkyl aminocaproate, and recovering lactam produced therefrom.
Abstract:
A process for preparing an N-alkyllactam with improved color quality, wherein from 0.01 to 10% by weight of a C1-10-alcohol or a compound which releases from 0.01 to 10% by weight of a C1-10-alcohol is added to the N-alkyllactam.A mixture comprising at least 99.0% by weight of an N-alkyllactam and in the range from 100 to 5000 ppm by weight of a C1-10-alcohol or of an acetal, aminal or of an orthoester which releases in the range from 100 to 5000 ppm by weight of a C1-10-alcohol.
Abstract:
Lactams, in particular ε-caprolactam, are produced by the hydrolytic cyclization of aminonitriles, in particular 6-aminocapronitrile, in the vapor phase in a plurality of adiabatic fixed bed reaction zones arranged in succession wherein at least a portion of the heat of the exothermic reaction is removed between each of the successive reaction zones. Conducting the reaction in such a manner requires less capital for the reactor itself. It has also been found that the product exiting such a reaction system can be directly fed to a distillation unit without the need of additional cooling or storing.
Abstract:
The present application describes amidinophenyl-pyrrolidines, -pyrrolines, and -isoxazolidines and derivatives thereof of formula I: ##STR1## or pharmaceutically acceptable salt forms thereof, wherein one of D and D' may be C(.dbd.NH)NH.sub.2 and the other H, and J.sup.1 and J.sup.2 may be O or CH.sub.2, which are useful as inhibitors of factor Xa.
Abstract:
Novel 2-bromo- and 2-nitroxy derivatives of 3-bromo- and 3-dibromo-4-oxo-azetidines, to processes for the preparation thereof and to the use thereof are provided. The azetidines of the present invention have the formula I ##STR1## wherein R.sup.1 is hydrogen or bromine, R.sup.2 is hydrogen or bromine, wherein at least one of R.sup.1 or R.sup.2 is bromine, R.sup.3 is hydrogen; Me.sub.2 --C.dbd.C--COOR.sup.4 wherein R.sup.4 is hydrogen, methyl, benzyl or some other carboxy-protective group, and X is bromine or nitroxy group (--ONO.sub.2). According to the invention 2-bromo- and 2-nitroxy derivatives of 3-bromo- and 3-dibromo-4-oxo-azetidines are prepared by reacting derivatives of protected penicillanic acid 1,1-dioxides with DBN reactant (1,5-diazabicyclo/3.4.0/non-5-ene) and then the obtained DBN salt of sulfinic acid or isolated sulfinic acid is treated with thionyl chloride and, after eliminating thionyl chloride by evaporation, the obtained residue is passed through a silica gel column with methylene chloride or some other solvent as eluant or the obtained residue is dissolved in tetrahydrofuran or some other suitable solvent and treated with tetrabutyl ammonium bromide and after the treatment a derivative of 2-bromo, 3-bromo or 2-bromo-3,3-dibromo-4-oxo-azetidine is isolated, which derivative may be subjected to a reaction with silver nitrate in 2-propanol and, after the treatment of the reaction mixture, derivatives of 2-nitroxy-,3-bromo- or 2-nitroxy-3,3-dibromo-4-oxo-azetidine are isolated. The obtained substances are useful intermediates in the syntheses of beta lactam analogons or as components in formulations having antibacterial, inhibitory, antitumour or antagonistic action.